Laura Ginocchi

637 total citations
17 papers, 183 citations indexed

About

Laura Ginocchi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hepatology. According to data from OpenAlex, Laura Ginocchi has authored 17 papers receiving a total of 183 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Hepatology. Recurrent topics in Laura Ginocchi's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Laura Ginocchi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Laura Ginocchi collaborates with scholars based in Italy, Netherlands and Germany. Laura Ginocchi's co-authors include Alfredo Falcone, Enrico Vasile, Chiara Caparello, M Lucchesi, Lorenzo Fornaro, Gianluca Masi, Ugo Boggi, Franco Mosca, Carla Cappelli and Monica Lencioni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Laura Ginocchi

16 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Ginocchi Italy 8 119 67 47 44 27 17 183
Elena Molina Roldán Spain 8 68 0.6× 67 1.0× 63 1.3× 38 0.9× 14 0.5× 16 178
Silvana Acquafredda Italy 6 159 1.3× 94 1.4× 42 0.9× 24 0.5× 19 0.7× 8 237
Noel Chia Australia 7 201 1.7× 46 0.7× 37 0.8× 54 1.2× 8 0.3× 10 282
Haiqing Ni China 7 207 1.7× 65 1.0× 34 0.7× 23 0.5× 37 1.4× 10 309
Ina Valeria Zurlo Italy 6 105 0.9× 89 1.3× 36 0.8× 42 1.0× 15 0.6× 24 191
Youpei Lin China 7 62 0.5× 29 0.4× 74 1.6× 21 0.5× 23 0.9× 15 173
Nigel Biswas–Baldwin United Kingdom 5 140 1.2× 124 1.9× 85 1.8× 50 1.1× 21 0.8× 9 252
Rocco Giannicola Italy 8 99 0.8× 62 0.9× 34 0.7× 22 0.5× 9 0.3× 16 196
Mei Xie China 11 100 0.8× 99 1.5× 93 2.0× 27 0.6× 17 0.6× 28 251
Miao Huang China 9 184 1.5× 159 2.4× 61 1.3× 23 0.5× 33 1.2× 17 298

Countries citing papers authored by Laura Ginocchi

Since Specialization
Citations

This map shows the geographic impact of Laura Ginocchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Ginocchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Ginocchi more than expected).

Fields of papers citing papers by Laura Ginocchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Ginocchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Ginocchi. The network helps show where Laura Ginocchi may publish in the future.

Co-authorship network of co-authors of Laura Ginocchi

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Ginocchi. A scholar is included among the top collaborators of Laura Ginocchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Ginocchi. Laura Ginocchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fiorentini, Giammaria, Donatella Sarti, Andrea Mambrini, et al.. (2025). Locoregional Hyperthermia in Cancer Treatment: A Narrative Review with Updates and Perspectives. SHILAP Revista de lepidopterología. 5(2). 26–26.
2.
Comandatore, Annalisa, Laura Ginocchi, Laura L. Meijer, et al.. (2024). Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer. SHILAP Revista de lepidopterología. 5. 100152–100152. 2 indexed citations
3.
Petrini, Iacopo, Monica Lencioni, Enrico Vasile, et al.. (2017). EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas. Cancer Biomarkers. 21(3). 731–741. 15 indexed citations
4.
Fontana, Andrea, Laura Ginocchi, Guido Bocci, et al.. (2016). Cardiac safety of adjuvant non-pegylated liposomal doxorubicin combined with cyclophosphamide and followed by paclitaxel in older breast cancer patients. The Breast. 31. 186–191. 8 indexed citations
5.
Falcone, Alfredo, Chiara Cremolini, Fotios Loupakis, et al.. (2016). FOLFOXIRI plus bevacizumab (bev) followed by maintenance with bev alone or bev plus metronomic chemotherapy (metroCT) in metastatic colorectal cancer (mCRC): The phase II randomized MOMA trial. Annals of Oncology. 27. vi560–vi560. 4 indexed citations
6.
Solini, Anna, Vittorio Simeon, Lisa Derosa, et al.. (2015). Genetic interaction ofP2X7receptor andVEGFR-2polymorphisms identifies a favorable prognostic profile in prostate cancer patients. Oncotarget. 6(30). 28743–28754. 22 indexed citations
7.
Fornaro, Lorenzo, Enrico Vasile, Carmelo Tibaldi, et al.. (2014). EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition. Journal of Experimental & Clinical Cancer Research. 33(1). 77–77. 11 indexed citations
8.
Vasile, Enrico, Niccola Funel, Nelide De Lio, et al.. (2013). Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms. European Journal of Surgical Oncology. 39(4). 396–403. 30 indexed citations
9.
Antonuzzo, Andrea, Enrico Vasile, M Lucchesi, et al.. (2013). A new model of early supportive care and symptoms management: The experience of Pisa medical oncology.. Journal of Clinical Oncology. 31(15_suppl). e20711–e20711. 1 indexed citations
10.
Vasile, Enrico, Nelide De Lio, Carla Cappelli, et al.. (2013). Phase II study of neoadjuvant chemotherapy with modified FOLFOXIRI in borderline resectable or unresectable stage III pancreatic cancer.. Journal of Clinical Oncology. 31(15_suppl). 4062–4062. 7 indexed citations
11.
Vasile, Enrico, Nelide De Lio, Carla Cappelli, et al.. (2012). Neoadjuvant Modified Folfoxiri in Locally advanced Pancreatic Cancer. Annals of Oncology. 23. ix241–ix241. 3 indexed citations
12.
Ginocchi, Laura, Enrico Vasile, M Lucchesi, et al.. (2012). Modified Folfoxiri in advanced Pancreatic Cancer. Annals of Oncology. 23. ix238–ix238. 1 indexed citations
13.
Ginocchi, Laura, Enrico Vasile, M Lucchesi, et al.. (2012). Modified FOLFOXIRI in Advanced Pancreatic Cancer. Università degli Studi di Napoli Federico II. 2 indexed citations
14.
Vasile, Enrico, Nelide De Lio, Carla Cappelli, et al.. (2012). Phase II study of neoadjuvant modified folfoxiri in locally advanced pancreatic cancer.. 1 indexed citations
15.
Fornaro, Lorenzo, M Lucchesi, Chiara Caparello, et al.. (2011). Anti-HER agents in gastric cancer: from bench to bedside. Nature Reviews Gastroenterology & Hepatology. 8(7). 369–383. 63 indexed citations
16.
Vasile, Enrico, Laura Ginocchi, Carmelo Tibaldi, et al.. (2010). Second-line Treatment for Non–Small-Cell Lung Cancer: One Size Does Not Fit All. Clinical Lung Cancer. 11(5). 320–327. 12 indexed citations
17.
Vasile, Enrico, Marco Del Chiaro, Niccola Funel, et al.. (2010). Prognostic relevance of lymph node metastases and adjuvant treatment for patients with invasive intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. CINECA IRIS Institutial research information system (University of Pisa). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Molina Roldán Breakdown of academic impact, for papers by Silvana Acquafredda Breakdown of academic impact, for papers by Noel Chia Breakdown of academic impact, for papers by Haiqing Ni Breakdown of academic impact, for papers by Ina Valeria Zurlo Breakdown of academic impact, for papers by Youpei Lin Breakdown of academic impact, for papers by Nigel Biswas–Baldwin Breakdown of academic impact, for papers by Rocco Giannicola Breakdown of academic impact, for papers by Mei Xie Breakdown of academic impact, for papers by Miao Huang
Rankless by CCL
2026